Northwest Biotherapeutics (NWBO) Long-Term Investments (2014 - 2016)

Northwest Biotherapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $77000.0 for Q2 2016.

• On a quarterly basis, Long-Term Investments fell 89.58% year-over-year to $77000.0 in Q2 2016; TTM through Jun 2016 was $77000.0, a 89.58% decrease from a year earlier, with the FY2015 full-year figure at $349000.0, down 80.17% from the prior year.
• Long-Term Investments eased to $77000.0 in Q2 2016 per NWBO's latest filing, from $214000.0 in the prior quarter.
• Across five years, Long-Term Investments topped out at $1.8 million in Q4 2014 and bottomed at $77000.0 in Q2 2016.
• The 3-year median for Long-Term Investments is $488000.0 (2015), against an average of $706428.6.
• Across the five-year window, Long-Term Investments slumped 80.17% in 2015 and slumped 89.58% in 2016, its largest moves.
• Year by year, Long-Term Investments stood at $1.8 million in 2014, then slumped by 80.17% to $349000.0 in 2015, then tumbled by 77.94% to $77000.0 in 2016.
• Per Business Quant, the three latest NWBO Long-Term Investments figures stand at $77000.0 (Q2 2016), $214000.0 (Q1 2016), and $349000.0 (Q4 2015).